CancerLinQ is a big data platform developed by the American Society of Clinical Oncology (ASCO) that aggregates clinical data from electronic health records for quality benchmarking and hypothesis ...
Cancer center leaders discuss how joining ConcertAI's CancerLinQ network cut QOPI data abstraction time, while enabling data insights and benchmarking.
Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial ASCO, through its wholly owned ...
An allegory that captures today’s health technology impasse is the legend of the Gordian knot. Alexander the Great faced the challenge of untying an intricate knot so entangled it was impossible to ...
ALEXANDRIA, VA--(Marketwired - February 22, 2017) - CancerLinQ LLC and the American Society for Radiation Oncology (ASTRO) are partnering to bring radiation oncology expertise to CancerLinQ and ...
ConcertAI has announced enhancements to its CancerLinQ Suite, incorporating AI-driven trial matching and contextualised patient insights. These updates aim to support oncologists and care teams in ...
The CancerLinQ big-data system, designed by the American Society of Clinical Oncology (ASCO), was discussed and demonstrated June 1 during the organization’s annual meeting for oncology professionals ...
ConcertAI will invest in CancerLinQ to provide its members with upgraded quality reporting, industry-leading real-world data, and AI-powered solutions for accelerated clinical trials in a multi-year ...
ConcertAI Expands CancerLinQ Suite with AI-Driven Trial Matching and Contextualized Patient Insights to Support Oncologists at the Point of Care New capabilities identify trial-eligible patients 3.3x ...
Collaborating with diverse stakeholders, including the FDA and the Surveillance, Epidemiology, and End Results program, CancerLinQ continues its efforts to harness big data to rapidly improve the ...
Please provide your email address to receive an email when new articles are posted on . ASCO today announced the partnership between its wholly owned subsidiary CancerLinQ and the software company SAP ...